Biomarkers in Alzheimer's disease clinical trials: 2025.

Osse AML, Zhou Y, Kinney JW, Hooyman A, Sengupta A, Fonseca J, Burstein AH, Owen M, Nisenbaum L, Fillit HM, Cheng F, Cummings JL

Open source

DOI
10.1002/trc2.70217
Published
2026 Jan-Mar
Container
Alzheimer's & dementia (New York, N. Y.)
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/trc2.70217,
  title = {Biomarkers in Alzheimer's disease clinical trials: 2025.},
  author = {Osse AML and Zhou Y and Kinney JW and Hooyman A and Sengupta A and Fonseca J and Burstein AH and Owen M and Nisenbaum L and Fillit HM and Cheng F and Cummings JL},
  year = {2026},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  doi = {10.1002/trc2.70217},
  url = {https://doi.org/10.1002/trc2.70217}
}

RIS

TY  - JOUR
TI  - Biomarkers in Alzheimer's disease clinical trials: 2025.
AU  - Osse AML
AU  - Zhou Y
AU  - Kinney JW
AU  - Hooyman A
AU  - Sengupta A
AU  - Fonseca J
AU  - Burstein AH
AU  - Owen M
AU  - Nisenbaum L
AU  - Fillit HM
AU  - Cheng F
AU  - Cummings JL
PY  - 2026
JO  - Alzheimer's & dementia (New York, N. Y.)
DO  - 10.1002/trc2.70217
UR  - https://doi.org/10.1002/trc2.70217
ER  - 

APA

AML, O., Y, Z., JW, K., A, H., A, S., J, F., AH, B., M, O., L, N., HM, F., F, C., & JL, C. (2026). Biomarkers in Alzheimer's disease clinical trials: 2025.. Alzheimer's & dementia (New York, N. Y.). https://doi.org/10.1002/trc2.70217

Source records